Approximately 66,000 people in the U.S. will be diagnosed with pancreatic cancer this year, according to the National Cancer Institute. Dr. Michael Wallace, a gastroenterologist at Mayo Clinic, warns that early signs of this deadly disease are easy to miss.
In March, Brian Principe became the first patient at Mayo Clinic in Florida to have surgery to implant a pump directly into his hepatic artery so he could receive liver-directed chemotherapy for his colon cancer. Mayo Clinic is the only center in North Florida to offer the therapy.
Advances in treatment including surgical innovations are helping women and their health care teams personalize care and improve quality of life.
As the sun rises above the St. Johns River and casts a glow on the glass buildings of downtown Jacksonville, Florida, Ann Mackey returns from a walk with her dog Maggie and prepares to attend a book club discussion. It's moments like these she has come to truly appreciate after treatment for breast cancer and multiple myeloma.
Dr. James Jakub, a Mayo Clinic surgical oncologist, explains that TIL therapy can be a one-time treatment for some patients diagnosed with advanced melanoma.
Radiation therapy has been used to treat cancer since the beginning of the 20th century. This type of treatment continues to be one of the most effective treatments for cancerous (malignant) and noncancerous (benign) brain tumors. How it is delivered — and the technology used — has continued to evolve and improve.
When Walter "Dick" Whetstone leaves his home in central South Carolina, he's usually wearing a paw print or, at the least, his school colors of orange and purple. The proud Clemson University alumnus didn't realize that what he wore to an appointment would earn him a nickname and a chance to help others.
Sylvester Pinckney is someone who knows a lot about teamwork. He was a star football player in high school and college; he and his wife, Sabrina, have raised a family together; and for more than 20 years, he has worked to promote the well-being of children throughout his community.
After crossing the Atlantic Ocean and meeting with a team at Mayo, John Cadwallader learned he was a candidate for chimeric antigen receptor-T cell therapy, or CAR-T. The personalized treatment collects a patient's T cells, which normally help fight off infections, and genetically engineers them to target cancer cells.
